Amanote Research
Register
Sign In
78. Overexpression of Non-Aggregatable Alpha-Synuclein Protects Against Human Wildtype Alpha-Synuclein Mediated Toxicity
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35882-8
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Inhibition of HDAC6 Activity Protects Dopaminergic Neurons From Alpha-Synuclein Toxicity
Scientific Reports
Multidisciplinary
Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes Against Alpha-Synuclein Toxicity
Molecular Cell
Cell Biology
Molecular Biology
Alpha-Synuclein Interactions With Membranes
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Journal of Neuroscience
Neuroscience
Region Specific Mitochondrial Impairment in Mice With Widespread Overexpression of Alpha-Synuclein
Neurobiology of Disease
Neurology
Alpha-Synuclein Disrupts Inter-Membrane Interactions
Biophysical Journal
Biophysics
Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization
PLoS ONE
Multidisciplinary
Structural Studies of Alpha-Synuclein Amyloid Filaments
Biophysical Journal
Biophysics
Alpha-Synuclein and Tau: Teammates in Neurodegeneration?
Molecular Neurodegeneration
Molecular Neuroscience
Neurology
Molecular Biology
Cellular